Melexis (ENXTBR:MELE) Following Mixed Earnings The Valuation Case Still Leans Higher
Why Melexis earnings are in focus now
Melexis (ENXTBR:MELE) just released second quarter and half year 2026 results, with higher sales alongside lower net income. This combination of revenue growth and weaker profitability is shaping current investor discussion.
See our latest analysis for Melexis.
The latest results arrive after a mixed price pattern for Melexis, with the share price up 17.28% year to date and a 1 year total shareholder return of 5.16%, but a 3 year total shareholder return that is 16.06% lower. This suggests momentum has cooled recently as investors reassess the balance between revenue growth and profitability.
If the earnings reaction has you looking beyond Melexis, this is a good moment to scan for other semiconductor suppliers and enablers through our 36 robotics and automation stocks
Bulls point to Melexis revenue growth and recent share price gain, while bears highlight pressure on net income and softer multi year returns. Which case does the current valuation support, given where the stock trades today?
Most Popular Narrative: 8.3% Undervalued
The most followed narrative values Melexis at €75.15, compared with the last close at €68.90. That gap is small enough that the story behind the numbers really matters.
Rising electrification in vehicles, including the shift to 48 volt architectures and advanced EV thermal management, supports sustained demand for motor drivers and current sensors. This may lift top line growth and support operating leverage as volumes scale.
Want to understand why this narrative supports a higher value for Melexis? The core assumptions hinge on steadier revenue progress, firmer margins and a future earnings multiple that needs careful scrutiny.
Result: Fair Value of €75.15 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this Melexis narrative also faces risks, including slower end market recovery and high channel inventories, which could pressure volumes and margins if demand disappoints.
Find out about the key risks to this Melexis narrative.
Next Steps
With both risks and rewards in view for Melexis, this is a good time to move quickly, test the assumptions yourself and weigh the 2 key rewards and 3 important warning signs
Looking for more investment ideas beyond Melexis?
If Melexis has you thinking more broadly about your portfolio, use this moment to size up other opportunities that could fit your goals and risk comfort.
- Focus on value oriented opportunities and scan the 252 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their underlying strength.
- Strengthen your income potential and review the 441 dividend fortresses that offer higher yields while still aiming for resilient business profiles.
- Reduce portfolio stress and filter for 303 resilient stocks with low risk scores that score well on stability so you are not relying on just one stock for peace of mind.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com